Updates

First to the future of cardiac PET

02
Oct

Heart disease is a danger like no other, meaning proper diagnosis is of paramount importance. PET scans have been, and continue to be, the best way to get such a diagnosis.

 

Full Text

06
Sep

POSITRON ANNOUNCES SALE OF ATTRIUS PET SCANNER

 

Niagara Falls, NY –September 5, 2018 – Positron Corporation (OTC:POSC)(the “Company”), a nuclear medicine healthcare company, is pleased to announce the sale of its Attrius PET scanner to a prominent cardiology practice in the US as they expand their services to... Read More

02
Aug

Positron Appoints New Management

POSITRON APPOINTS NEW MANAGEMENT

ADEL ABDULLAH PRESIDENT & AARON HARGRAVE VICE PRESIDENT

 

Niagara Falls, NY –August 2, 2018– Positron Corporation (OTC:POSC)(the “Company”), a nuclear medicine healthcare company, announces the appointment of Adel Abdullah  as its President. Mr. Abdullah will also serve as a... Read More

05
May

Nuclear medicine market to hit $2.2B by 2020

May 1, 2015 -- (AuntMinnie.com)  The worldwide nuclear medicine imaging market for PET and SPECT equipment is on track to produce $2.2 billion in revenues by 2020, according to a new report by RnR Market Research.

Two Asian giants will lead growth opportunities, with the Japanese market share set to increase by... Read More

06
Apr

Cardiovascular Disease Deaths Increasing Worldwide

THURSDAY, April 2, 2015 (HealthDay News) -- Despite medical advances, new research indicates that more people are dying of heart disease and stroke worldwide than did a quarter century ago because the global population is growing, and growing older. The study is published in the April 2 issue of the New England... Read More

18
Mar

March 10, 2015 — The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell analysis showing that the growth of nuclear medicine in the future will come through therapeutic radiopharmaceuticals (radiotherapeutics). Revenue for Xofigo – a product used in the... Read More